U.S. President Donald Trump expressed confidence on Wednesday that China will soon impose the death penalty for fentanyl manufacturing and trafficking, signaling renewed optimism for a bilateral crackdown on the opioid crisis. Speaking ahead of signing the HALT Fentanyl Act, Trump emphasized collaboration with Beijing to halt the flow of synthetic opioids, which have claimed over 450,000 American lives in the past decade.
Fentanyl, a powerful synthetic opioid, remains a top cause of overdose deaths in the U.S., and Washington continues to pressure Beijing to tighten control over precursor chemicals exported from China. Trump’s remarks follow a series of recent moves aimed at reining in the deadly drug trade, including the February imposition of 20% tariffs on Chinese goods linked to fentanyl-related issues.
“I think China’s going to go from doing nothing to issuing the death penalty for those producing fentanyl and sending it here,” Trump told reporters. He added that talks with Chinese leader Xi Jinping were progressing and that Beijing was taking “big steps” in response.
In recent weeks, China has added two more fentanyl precursors—4-piperidone and 1-boc-4-piperidone—to its list of controlled substances. Authorities have also ramped up enforcement, seizing over 2 tons of drugs and arresting 262 individuals for trafficking. Over 1,300 prosecutions and 700 arrests for drug-related money laundering have been reported this year, showing a 2.1% increase from last year.
China, however, has pushed back on U.S. demands to publicize its efforts prominently and has accused Washington of politicizing the fentanyl issue. Still, Trump’s latest remarks suggest a possible breakthrough in cooperation as both nations grapple with rising overdose deaths and escalating tensions.


Belarus Frees 123 Political Prisoners in U.S.-Brokered Deal Over Sanctions
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip
Sydney Bondi Beach Shooting Sparks Calls for Stronger Protection of Jewish Community in Australia
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Federal Judge Orders Restoration of SEVIS Status for Tufts PhD Student Rumeysa Ozturk
California, 18 States Sue to Block Trump’s $100,000 H-1B Visa Fee
U.S. State Department Reverts to Times New Roman in Push for “Professionalism”
Trump Weighs Reclassifying Marijuana as Schedule III, Potentially Transforming U.S. Cannabis Industry
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure
Ukraine Claims First-Ever Underwater Drone Strike on Russian Missile Submarine
Special Prosecutor Alleges Yoon Suk Yeol Sought North Korea Provocation to Justify Martial Law
DOJ Sues Loudoun County School Board Over Transgender Locker Room Policy
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
Trump Signs Executive Order to Establish National AI Regulation Standard
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing 



